Find policies, billing codes, payers, states, and providers
Loading...
Create a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsCreate a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsFind policies, billing codes, payers, states, and providers
CPT 86805: Donor Lymphocyte–Recipient Serum Crossmatch Test
CPT-86806-SEROLOGIC-CROSSMATCH-DONOR-LYMPHOCYTE-RECIPIENT-SERUMCPT 86806: Serologic Crossmatch for Transplant Compatibility
CPT-86807-HLA-ANTIBODY-SCREENING-TRANSPLANT-COMPATIBILITYCPT 86807: HLA Antibody Screening for Transplant Compatibility
CPT-86808-HLA-PERCENT-REACTIVE-ANTIBODY-SCREENINGCPT 86808: HLA Percent Reactive Antibody Screening
CPT-86812-HLA-CLASS-I-SINGLE-ANTIGEN-SEROLOGIC-TESTCPT 86812: HLA Class I Single Antigen Serologic Test
CPT-86813-HLA-CLASS-I-SEROLOGIC-TYPINGCPT 86813: HLA Class I Serologic Antigen Typing
CPT-86816-HLA-CLASS-II-SEROLOGIC-SINGLE-ANTIGEN-TYPING-DR-DQCPT 86816: HLA Class II Serologic Typing, Single Antigen (DR or DQ)
CPT-86817-HLA-CLASS-II-DR-DQ-SEROLOGIC-IDENTIFICATIONCPT 86817: HLA Class II (DR/DQ) Serologic Identification
CPT-86821-HLA-LYMPHOCYTE-CROSSMATCH-COMPATIBILITY-TESTCPT 86821: Lymphocyte Crossmatch for HLA Incompatibility
CPT-86825-HLA-CROSSMATCH-FLOW-CYTOMETRYCPT 86825: HLA Crossmatch by Non-Cytotoxic Method (e.g., Flow Cytometry)
Showing 1–10 of 20
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.